Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
与白蛋白结合域结合的 GRPR 靶向拮抗剂 RM26 用于 GRPR 靶向癌症治疗的临床前评估
期刊:Pharmaceutics
影响因子:4.9
doi:10.3390/pharmaceutics12100977
Ayman Abouzayed, Hanna Tano, Ábel Nagy, Sara S Rinne, Fadya Wadeea, Sharmishtaa Kumar, Kristina Westerlund, Vladimir Tolmachev, Amelie Eriksson Karlström, Anna Orlova
